Saltar al contenido
Merck

Successful treatment of ctx-m ESBL producing Escherichia coli relapsing pyelonephritis with long term pivmecillinam.

Scandinavian journal of infectious diseases (2007-07-27)
Lindsay E Nicolle, Michael R Mulvey
RESUMEN

Oral therapy options for pyelonephritis caused by ESBL producing E. coli are limited. We describe a woman with relapsing pyelonephritis due to a CTX-M ESBL E. coli who was cured with a prolonged course of pivmecillinam. This suggests pivmecillinam may be effective treatment for selected patients with pyelonephritis with these organisms.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Pivmecillinam, ≥98% (HPLC)